Back
Alterity Therapeutics Quote, Financials, Valuation and Earnings
The Mysterious VC Firm Behind Nvidia's Secret Weapon
Details Here!
Sell
22
ATHE
Alterity Therapeutics
Last Price:
1.19
Seasonality Move:
3.6%
7 Day Trial
ALL ACCESS PASS
$
7
U.S. Government Report Alert Tuesday
Discover the Secret LoopholeAlterity Therapeutics Price Quote
$1.19
+0.01 (+4.38%)
(Updated: November 6, 2024 at 4:59 AM ET)
Alterity Therapeutics Key Stats
Sell
22
Alterity Therapeutics (ATHE)
is a Sell
Day range:
$1.17 - $1.19
52-week range:
$1.01 - $5.41
Dividend yield:
0%
P/E ratio:
0.00
P/S ratio:
0.00
P/B ratio:
0%
Volume:
5.3K
Avg. volume:
10.8K
1-year change:
-50.65%
Market cap:
$10.4M
Revenue:
$0
EPS:
$-0.71
How Much Does Alterity Therapeutics Make?
-
How Much Are Alterity Therapeutics's Sales Annually?
ATHE Revenues are $0 -
How Much Profit Does Alterity Therapeutics's Make A Year?
ATHE net income is -$12.5M
Is Alterity Therapeutics Growing As A Company?
-
What Is Alterity Therapeutics's Growth Rate Quarterly?
Quarterly YoY revenue growth is -0.39% -
What Is Alterity Therapeutics's EPS Quarterly YoY Growth Rate?
Quarterly, year-over-year diluted EPS growth rate is 0%
Alterity Therapeutics Stock Price Performance
-
Did Alterity Therapeutics Stock Go Up Last Month?
Alterity Therapeutics share price went down by -15.4% last month -
Did ATHE's Share Price Rise Over The Last Year?
ATHE share price fell by -50.65% over the past 1 year
What Is Alterity Therapeutics 52-Week High & Low?
-
What Is Alterity Therapeutics’s 52-Week High Share Price?
Alterity Therapeutics has traded as high as $5.41 over the past 52 weeks -
What Is Alterity Therapeutics’s 52-Week Low Share Price?
Alterity Therapeutics has traded as low as $1.01 over the past 52 weeks
Alterity Therapeutics Price To Free Cash Flow
Data Unavailable
Is It Risky To Buy Alterity Therapeutics?
-
How Much Debt Does Alterity Therapeutics Have?
Total long term debt quarterly is $0 -
How Much Cash Does Alterity Therapeutics Have?
Cash and short term investments quarterly total is $26.9M -
What Is Alterity Therapeutics’s Book Value Per Share?
Book value per share is 0.78
Is Alterity Therapeutics Cash Flow Positive?
-
What Is ATHE Cash Flow From Operations?
Cash flow from operations (TTM) is -$10.1M -
What Is Alterity Therapeutics’s Cash Flow From Financing?
Cash flow from financing (TTM) is $33.8M -
What Is Alterity Therapeutics’s Cash Flow From Investing?
Cash flow from investing (TTM) is -$4.4K
Alterity Therapeutics Return On Invested Capital
Data Unavailable
Alterity Therapeutics Earnings Date & Stock Price
-
What Is Alterity Therapeutics's Stock Price Today?
A single share of ATHE can be purchased today for 1.18 -
What Is Alterity Therapeutics’s Stock Symbol?
Alterity Therapeutics trades on the nasdaq under the ticker symbol: ATHE -
When Is Alterity Therapeutics’s Next Earnings Date?
The next quarterly earnings date for Alterity Therapeutics is scheduled on November 6, 2024 -
When Is ATHE's next ex-dividend date?
Alterity Therapeutics's next ex-dividend date is November 6, 2024 -
How To Buy Alterity Therapeutics Stock?
You can buy Alterity Therapeutics shares by opening an account at a top tier brokerage firm, such as TD Ameritrade or tastyworks.
Alterity Therapeutics Competitors
-
Who Are Alterity Therapeutics's Competitors?
Below is a list of companies who compete with Alterity Therapeutics or are related in some way:
Alterity Therapeutics Dividend Yield
-
What Is ATHE Dividend Yield?
Alterity Therapeutics’s dividend yield currently is 0% -
What Is Alterity Therapeutics’s Payout Ratio?
Alterity Therapeutics’s payout ratio is 0% -
When Did Alterity Therapeutics Last Pay A Dividend?
The latest dividend pay date is November 6, 2024 -
What Is Alterity Therapeutics’s Dividend Per Share?
Alterity Therapeutics pays a dividend of $0.00 per share
Alterity Therapeutics Analyst Estimates
| YoY Growth | Past Surprise | |
|---|---|---|
| EPS: | 0% | 0% |
| Revenue: | -38.88% | 0% |
Analyst Recommendations
| Buy Recommendations: | 1 |
|---|---|
| Hold Recommendations: | 0 |
| Sell Recommendations: | 0 |
| Price Target: | 4.00 |
| Upside from Last Price: | 237.72% |